ACAD
ACAD
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
1
$69K
Total Volume
$69K
1 transactions
Net Activity
$69K
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Schneyer Mark C.
EVP, CFO
$69K total
Quick Actions
ACAD has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at ACAD (ACAD) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $69K.
The net insider activity for ACAD shows a net selling bias of $69K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Schneyer Mark C. (EVP, CFO), who traded 3.3K shares valued at $69K on Oct 30, 2026.
symbol__ Stock Quote Price and Forecast
Acadia Pharmaceuticals Inc. (ACAD) Stock Price, News, Quote & History
Acadia Pharmaceuticals Inc. (ACAD) stock price, news, quote and history
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal
ACAD - Acadia Pharmaceuticals Inc Stock Price and Quote
Acadia Pharmaceuticals (ACAD) Stock Dropped, So What Is Driving Attention Now?
Related News & Analyst Reports
Read original insights and educational research covering ACAD and the Unknown sector.
How CFOs Trade vs. CEOs: A Data-Driven Analysis of Who Reads Markets Better
Decades of academic research consistently shows that CFOs are more accurate insiders than CEOs when it comes to stock purchases. This analysis explains why — covering the informational advantages of the CFO role, how their trading patterns differ from CEOs, and what specific CFO buying patterns investors should watch for.
Insider Buying vs. Stock Buybacks: Which Signal Should You Follow?
Corporate buybacks and insider purchases are both bullish signals — but they differ fundamentally in what they mean, how reliable they are, and how you should incorporate them into your investment analysis. This guide breaks down the mechanics, academic research, and practical applications of both signals.
Why 10b5-1 Cooling-Off Periods Were Updated: A Historical Review
The SEC's 2023 10b5-1 reforms imposed mandatory cooling-off periods, 90 days for officers, 120 days for Section 16 reporters. This historical review explains what abuses the changes targeted, which academic studies drove the reform, and how the new rules affect insider signal interpretation.
FAQs About ACAD Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ACAD.